Skip to main content
GRX
NYSE Unknown

Mario Gabelli Makes Substantial $18M Purchase of Preferred Shares

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$9.635
Mkt Cap
$152.158M
52W Low
$8.93
52W High
$10.48
Market data snapshot near publication time

summarizeSummary

Mario J. Gabelli, a Director and 10% owner, significantly increased his stake in Gabelli Healthcare & WellnessRx Trust with an $18 million open market purchase of preferred shares, signaling strong conviction.


check_boxKey Events

  • Significant Insider Purchase

    Mario J. Gabelli, a Director and 10% owner, acquired $18,000,000 worth of Series E Cumulative Preferred Shares through open market transactions on December 26, 2025.

  • Purchase at Premium to Current Price

    The shares were purchased at $10.00 per share, which is slightly above the current market price of $9.635.

  • Net Increase in Holdings

    Despite a concurrent $2,000,000 disposition of shares via a put option, the overall activity resulted in a net increase of $16,000,000 in Gabelli's beneficial ownership.

  • Strong Vote of Confidence

    This substantial investment by a key insider signals strong conviction in the company's value and future prospects.


auto_awesomeAnalysis

Mario J. Gabelli, a prominent investor, Director, and 10% owner, executed a substantial open market purchase of Gabelli Healthcare & WellnessRx Trust's Series E Cumulative Preferred Shares. This $18 million acquisition, representing a significant portion of the company's market capitalization, demonstrates a strong vote of confidence from a key insider. The shares were purchased at $10.00, slightly above the current market price of $9.635. While there was a concurrent $2 million disposition via a put option, the net effect is a considerable increase in Gabelli's beneficial ownership. Investors should view this large insider buy as a positive indicator of perceived value.

At the time of this filing, GRX was trading at $9.64 on NYSE in the Unknown sector, with a market capitalization of approximately $152.2M. The 52-week trading range was $8.93 to $10.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed GRX - Latest Insights

GRX
Jan 02, 2026, 5:35 PM EST
Filing Type: 4
Importance Score:
8